MTOR and neoplasm: In tumour cells, overexpression of death-associated protein kinase 1 (DAPK1) mediated the disruption of the interaction between tuberous sclerosis complex proteins 1 and 2 (TSC-1/TSC-2), resulting in the activation of the mTOR pathway.